A nationwide survey of hepatitis E viral infection in French blood donors

Hepatology

Volumn 63, Issue 4, 2016, Pages 1145-1154

  Mansuy, Jean Michel ^a   Gallian, Pierre ^b,c   Dimeglio, Chloé ^a,d   Saune, Karine ^a,d   Arnaud, Catherine ^a,d   Pelletier, Bertrand ^b   Morel, Pascal ^b   Legrand, Dominique ^b   Tiberghien, Pierre ^b,e   Izopet, Jacques ^a,d  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c Aix Marseille University IRD 190 Inserm 1207   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; HEPATITIS ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGE; ARTICLE; BLOOD DONOR; EATING HABIT; FOOD INTAKE; GEOGRAPHY; HEALTH SURVEY; HEPATITIS E; HUMAN; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEROPREVALENCE; BLOOD; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRANCE; HEPATITIS E VIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NONPARAMETRIC TEST; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA;

ADULT; BLOOD DONORS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DISEASE TRANSMISSION, INFECTIOUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FRANCE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; SEROEPIDEMIOLOGIC STUDIES; STATISTICS, NONPARAMETRIC; SURVEYS AND QUESTIONNAIRES;

EID: 84961839154     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28436     Document Type: Article

References (40)

1. Meng XJ, Anderson D, Arankalle VA, Emerson SU, Harrison TJ, Jameel S, et al. Hepeviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ, eds. Virus Taxonomy: Ninth Report of the ICTV. London: Elsevier/Academic Press; 2012:1021-1028. http://www.ictvonline.org/taxonomyHistory.asp
2. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, et al. Hepatitis E. Lancet 2012;379:2477-2488.
3. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev 2014;27:116-138.
4. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011;140:1481-1489.
5. Mansuy JM, Abravanel F, Miedouge M, Mengelle C, Merviel C, Dubois M, et al. Acute hepatitis E in south-west France over a 5-year period. J Clin Virol 2009;44:74-77.
6. Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010;202:825-834.
7. Chaussade H, Rigaud E, Allix A, Carpentier A, Touze A, Delzescaux D, et al. Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals. J Clin Virol 2013;58:504-508.
8. Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014;384:1766-1773.
9. Gallian P, Lhomme S, Piquet Y, Saune K, Abravanel F, Assal A, et al. Hepatitis E virus infections in blood donors, France. Emerg Infect Dis 2014;20:1914-1917.
10. Cleland A, Smith L, Crossan C, Blatchford O, Dalton HR, Scobie L, et al. Hepatitis E virus in Scottish blood donors. Vox Sang 2013;105:283-289.
11. Mansuy JM, Bendall R, Legrand-Abravanel F, Saune K, Miedouge M, Ellis V, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011;17:2309-2312.
12. Boutrouille A, Bakkali-Kassimi L, Cruciere C, Pavio N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 2007;45:2009-2010.
13. Zhang J, Ge SX, Huang GY, Li SW, He ZQ, Wang YB, et al. Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model. J Med Virol 2003;71:518-526.
14. Avellon A, Morago L, Garcia-Galera del Carmen M, Munoz M, Echevarria JM. Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection. J Med Virol 2015;87:1934-1939.
15. Abravanel F, Chapuy-Regaud S, Lhomme S, Miedouge M, Peron JM, Alric L, et al. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol 2013;58:624-628.
16. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003;3:21.
17. Deddens JA, Petersen MR. Approaches for estimating prevalence ratios. Occup Environ Med 2008;65:501-506.
18. Sauleda S, Ong E, Bes M, Janssen A, Cory R, Babizki M, et al. Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). Transfusion 2015;55:972-979.
19. Wenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2013;207:497-500.
20. Slot E, Hogema BM, Riezebos-Brilman A, Kok TM, Molier M, Zaaijer HL. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013;18:20550.
21. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010;82:799-805.
22. Hogema BM, Molier M, Slot E, Zaaijer HL. Past and present of hepatitis E in The Netherlands. Transfusion 2014;54:3092-3096.
23. Holm DK, Moessner BK, Engle RE, Zaaijer HL, Georgsen J, Purcell RH, et al. Declining prevalence of hepatitis E antibodies among Danish blood donors. Transfusion 2015;55:1662-1667.
24. Teshale EH, Denniston MM, Drobeniuc J, Kamili S, Teo CG, Holmberg SD. Decline in hepatitis E virus antibody prevalence in the United States from 1988-1994 to 2009-2010. J Infect Dis 2015;211:366-373.
25. Mansuy JM, Saune K, Rech H, Abravanel F, Mengelle C, L'Homme S, et al. Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011. Euro Surveill 2015;20:27-34.
26. Christensen PB, Engle RE, Hjort C, Homburg KM, Vach W, Georgsen J, et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008;47:1026-1031.
27. Wen GP, Tang ZM, Yang F, Zhang K, Ji WF, Cai W, et al. A valuable antigen detection method for diagnosis of acute hepatitis E. J Clin Microbiol 2015;53:782-788.
28. Rose N, Lunazzi A, Dorenlor V, Merbah T, Eono F, Eloit M, et al. High prevalence of hepatitis E virus in French domestic pigs. Comp Immunol Microbiol Infect Dis 2011;34:419-427.
29. Pavio N, Merbah T, Thebault A. Frequent hepatitis E virus contamination in food containing raw pork liver, France. Emerg Infect Dis 2014;20:1925-1927.
30. Renou C, Roque-Afonso AM, Pavio N. Foodborne transmission of hepatitis E virus from raw pork liver sausage, France. Emerg Infect Dis 2014;20:1945-1947.
31. Rutjes SA, Bouwknegt M, van der Giessen JW, de Roda Husman AM, Reusken CB. Seroprevalence of hepatitis E virus in pigs from different farming systems in The Netherlands. J Food Prot 2014;77:640-642.
32. Walachowski S, Dorenlor V, Lefevre J, Lunazzi A, Eono F, Merbah T, et al. Risk factors associated with the presence of hepatitis E virus in livers and seroprevalence in slaughter-age pigs: a retrospective study of 90 swine farms in France. Epidemiol Infect 2014;142:1934-1944.
33. Kaba M, Davoust B, Marie JL, Colson P. Detection of hepatitis E virus in wild boar (Sus scrofa) livers. Vet J 2010;186:259-261.
34. Carpentier A, Chaussade H, Rigaud E, Rodriguez J, Berthault C, Boue F, et al. High hepatitis E virus seroprevalence in forestry workers and in wild boars in France. J Clin Microbiol 2012;50:2888-2893.
35. Lhomme S, Top S, Bertagnoli S, Dubois M, Guerin JL, Izopet J. Wildlife reservoir for hepatitis E virus, southwestern France. Emerg Infect Dis 2015;21:1224-1226.
36. Cook N, van der Poel WH. Survival and elimination of hepatitis E virus: a review. Food Environ Virol 2015;7:189-194.
37. Girones R, Carratala A, Calgua B, Calvo M, Rodriguez-Manzano J, Emerson S. Chlorine inactivation of hepatitis E virus and human adenovirus 2 in water. J Water Health 2014;12:436-442.
38. Rodriguez-Manzano J, Miagostovich M, Hundesa A, Clemente-Casares P, Carratala A, Buti M, et al. Analysis of the evolution in the circulation of HAV and HEV in eastern Spain by testing urban sewage samples. J Water Health 2010;8:346-354.
39. Rutjes SA, Lodder WJ, Lodder-Verschoor F, van den Berg HH, Vennema H, Duizer E, et al. Sources of hepatitis E virus genotype 3 in The Netherlands. Emerg Infect Dis 2009;15:381-387.
40. Song YJ, Jeong HJ, Kim YJ, Lee SW, Lee JB, Park SY, et al. Analysis of complete genome sequences of swine hepatitis E virus and possible risk factors for transmission of HEV to humans in Korea. J Med Virol 2010;82:583-591.